Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022
Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022

Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Increased Target to $4.5 on, Jan 3rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-4-5-on-jan-3rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "ADMA Biologics, Inc." (ADMA) at Strong Buy with Increased Target from $4 to $4.5 on, Jan 3rd, 2023.

Raghuram has made no other calls on ADMA in the last 4 months.



There is 1 other peer that has a rating on ADMA. Out of the 1 peers that are also analyzing ADMA, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Anthony Petrone of "Mizuho" Maintained at Strong Buy with Increased Target to $6 on, Thursday, November 10th, 2022

Publication Contributing Sources